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Abstract
Aims/hypothesis The aim of the study was to clarify
whether a therapeutic intervention focused on lifestyle
modification affected the incidence of vascular complica-
tions in patients with established diabetes.
Methods A total of 2,033 eligible Japanese men and
women aged 40–70 years with type 2 diabetes from 59
institutes were randomised to a conventional treatment
group (CON), which continued to receive the usual care,
and a lifestyle intervention group (INT), which received
education on lifestyle modification regarding dietary habits,
physical activities and adherence to treatment by telephone
counselling and at each outpatient clinic visit, in addition to
the usual care. Randomisation and open-label allocation
were done by a central computer system. Primary analysis
regarding measurements of control status and occurrence of
macro- and microvascular complications was based on
1,304 participants followed for an 8 year period.
Results Although status of control of most classic cardio-
vascular risk factors, including body weight, glycaemia,
serum lipids and BP, did not differ between groups during
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Meier analysis (p=0.02 by logrank test) and by multivariate
Cox analysis (HR 0.62, 95% CI 0.39–0.98, p=0.04). The
incidence of CHD, retinopathy and nephropathy did not
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another significant independent risk factor for stroke.
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Introduction
Lifestyle management through patient education plays a
crucial role in prevention and care of diabetes. It is well
established that lifestyle interventions, including diet and/or
exercise, can prevent type 2 diabetes [1–6] as well as
ameliorate glycaemia and other risk factors for complica-
tions [7–12] in patients with established diabetes. Recent
reports of two studies that examined the effect of a lifestyle
intervention on individuals with impaired glucose tolerance
(IGT) over a long-term follow-up period (the China Da
Qing Diabetes Prevention Study [13] and the Finnish
Diabetes Prevention Study [14]), failed to show significant
effects on cardiovascular disease (CVD) events or mortal-
ity. However, it is not known whether an intervention
mainly focusing on lifestyle modification through patient
education could prevent the occurrence of complications in
patients with established diabetes, although there have been
af e ws t u d i e s[ 15, 16] on lifestyle modification in
combination with pharmacotherapy for hyperglycaemia,
hypertension and dyslipidaemia in patients with type 2
diabetes.
The Japan Diabetes Complications Study (JDCS), a
nationwide randomised controlled study of Japanese
patients with type 2 diabetes, was designed to clarify whether
a long-term therapeutic intervention mainly focused on
lifestyle education has an effect on the incidence of diabetic
macro- and microvascular complication events in patients
with established type 2 diabetes (see Electronic supplemen-
tary material for members of JDCS). Another aim of this
study was to clarify pathophysiological characteristics in
East Asian patients with type 2 diabetes [17–20]. We
previously published a 3 year interim report [21]s h o w i n g
significant but only limited improvement in glycaemia and
no improvement in body weight, BP and serum lipids as a
result of lifestyle modifications in patients with type 2
diabetes. This result was quite consistent with other
subsequent studies with similar observation periods [8, 11,
22, 23]. The present report shows results after 8 years of an
investigation that focused on the incidence of macro- and
microvascular complications of diabetes.
Methods
Recruitment of patients Participants in the study were
previously diagnosed patients with type 2 diabetes aged
40–70 years whose HbA1c levels were ≥6.5%. From
outpatient clinics in 59 university and general hospitals
nationwide that specialise in diabetes care, a total of 2,205
patients (mean age 58.6 years; 47% women) were initially
registered from January 1995 to March 1996. Excluded
were patients with a history of angina pectoris, myocardial
infarction, stroke, peripheral arterial disease, familial hyper-
cholesterolaemia, type III hyperlipidaemia, non-diabetic
nephropathy, nephrotic syndrome, pre-proliferative and
proliferative retinopathy, intra-ocular surgeries, serum cre-
atinine levels >120 μmol/l, and mean values of two spot
urine examinations for an albumin excretion rate of
<150 mg/g creatinine. Diabetes mellitus and IGT were
diagnosed according to the Report of the Committee of the
Japan Diabetes Society on the Classification and Diagnostic
Criteria of Diabetes Mellitus, which is almost identical in
terms of cut-off values for glucose levels to those of the
WHO. The protocol for the study, which is in accordance
with the Declaration of Helsinki and the Ethical Guidelines
for Clinical/Epidemiological Studies of the Japanese Min-
istry of Health, Labour and Welfare, received ethical
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420 Diabetologia (2010) 53:419–428approval from the institutional review boards of all of the
participating institutes (RCT registration number was
C000000222 in www.umin.ac.jp). Written informed con-
sent was obtained from all patients enrolled.
Allocation of patients Before April 1996, when the inter-
vention began, patients who did not meet the eligibility
criteria were excluded. Finally, a total of 2,033 patients
aged 58.5±6.9 years and who had diabetes for a duration of
10.9±7.2 years (both mean ± SD) were included from the
present analysis. Figure 1 is a flow diagram of the JDCS.
Patients were allocated randomly into either a lifestyle
intervention (INT) group or a conventional treatment
(CON) group. Randomisation and all analyses were done
by a central computer at our database centre. This study
was open-labelled and the interventions for the INT group
were continued until March 2003.
Lifestyle intervention As basal therapeutic management of
all patients in both the CON and INT groups, regular
specialists’ care was provided throughout the study period
and patients were treated as they were before the study
started. This included dietary advice by an administrative
dietitian, using the ‘Food Exchange Lists Dietary Guidance
for Persons with Diabetes’ [24].
In addition to this routine conventional treatment,
education of patients in the INT group was given through
individual counselling on dietary habits, physical activities
and adherence to treatment, including taking medicine
properly. Counselling was provided by physicians, nurses,
dietitians and other co-medical staff during each outpatient
clinic visit. Patients in the INT group had a typically
5–10 min longer interview than the patients in the CON
group at each clinic visit for a discussion on possible causes
of any changes in HbA1c levels, weight and other control
variables from the previous visit, with emphasis on lifestyle
changes. For example, when it was revealed that control of
glycaemic and other variables had worsened, that dietary
intake, including quantity and content, and alcohol intake
had changed, that patterns of physical activity had changed
or that patients tended to forget to take their medicine,
possible strategies for improving lifestyle and habits were
discussed. Furthermore, patients in the INT group also
received additional advice regarding one or two particular
topic(s) at each visit and were given educational material
consisting of 23 brochures that discussed various aspects of
diabetes care with an emphasis on the importance of
lifestyle and behavioural changes such as ‘Why am I obese
even if I do not eat so much?’, ‘Tips for continuing
exercise’, ‘What kinds of stress affect the control of
diabetes’ or ‘Is your triglyceride level OK?’.
Patients in the INT group also received 15 min telephone
counselling sessions at least once every 2 weeks by nurses,
dietitians and psychotherapists who were trained in diabetes
education. These telephone sessions were performed based
on a structured and uniform format. Additional counselling
sessions were encouraged at any convenient time, depend-
ing on the needs of patients in the INT group. A diary to
record the progress of laboratory and other data was
distributed to the INT patients to provide better feedback
on therapeutic results. A pedometer was also distributed to
INT patients for objective exercise assessment.
Goals were set for patients in the INT group and their
physicians: i.e. HbA1c level <6.5%; BMI <22 kg/m
2;
BP <140/85 mmHg; serum cholesterol level <5.72 mmol/l;
serum triacylglycerol level <1.65 mmol/l; serum HDL-
cholesterol >1.04 mmol/l; WHR <0.9 for men and <0.8 for
women; smoking cessation; and abstinence from alcohol.
Goals regarding BP and serum cholesterol levels were
updated in accord with the revision of guidelines made by
the Japan Diabetes Society, which were <130/80 mmHg and
<5.17 mmol/l, respectively.
2,033 patients with type 2 diabetes 
(40–70 years old, women: 47%)
Intervention group: 
1,017
No. unretrieved
case records
Year 1   10
Year 2   24
Year 3   29
Year 4   31
Year 5   35
Year 6   52
Year 7   28
Year 8   33
Followed in year 8:  681
Retracted informed consent: 40
Died: 54
Control group:
1,016
No. unretrieved 
case records
Year 1   13
Year 2   40
Year 3   40
Year 4   47
Year 5   28
Year 6   58
Year 7   34
Year 8   50
Followed in year 8:  623
Retracted informed consent: 40
Died:  43
Fig. 1 Flow diagram of the JDCS
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poor control (HbA1c >8.0%, serum total cholesterol level
>5.72 mmol/l, serum triacylglycerol level >1.65 mmol/l or
BMI >22 kg/m
2) were identified and sent additional
educational material. At the same time, their physicians
were encouraged to strengthen the intervention through
increasing time for education by telephone or at clinic visits
or recommending hospital admissions for education.
Changes in medication including insulin and oral antihy-
pertension/dyslipidaemia agents were not restricted in either
group and were made based on therapeutic necessity.
Assessment of lifestyle Extensive lifestyle surveys were
performed at baseline and 5 years after the start of the
intervention in both groups. We used detailed question-
naires for patients to determine dietary (including alcohol
drinking) content, amount of exercise and smoking rate.
The dietary survey comprised food records and a food
frequency questionnaire, results of which were analysed by
an administrative dietitian using standardised software for
population-based surveys and nutrition counselling in Japan
(EIYO-KUN v.4.5, manufactured at Shikoku University
Nutrition Database) [25] based on the Standard Tables of
Food Composition in Japan [26] edited by the Japanese
Ministry of Education, Culture, Sports, Science and
Technology. Physical activity was determined by a ques-
tionnaire that inquired about types of exercise (walking,
jogging, tennis, etc) and average time (min) spent exercis-
ing per day at baseline and the Baecke’s Total Physical
Activity Index [27] at the fifth year.
Clinical and laboratory measurements Mean values of at
least two measurements each year were obtained for the
following variables: HbA1c, fasting plasma glucose/insulin/
C-peptide, serum lipids/creatinine/urea nitrogen, and urine
analysis. All other measurements including those for body
weight, BP and WHR and a neurological/ophthalmologi-
cal examination were done at least once yearly, with a
mean value obtained if measurements were done twice a
year. HbA1c assays were standardised by the Laboratory
Test Committee of the Japan Diabetes Society, with 5.8%
as the upper normal limit. All other laboratory tests were
done by standard methods in each clinic. Electrocardio-
grams and chest x-rays were performed annually. Patients
were assessed yearly after the baseline evaluation.
Endpoints of the study Primary outcomes of the study were
development and progression of microangiopathy and
occurrence of macrovascular complication events. Micro-
angiopathy endpoints consisted of those related to retino-
pathies and nephropathies. Retinopathy was evaluated by
qualified ophthalmologists using the following classifica-
tion designed for this research: Stage 0, no retinopathy;
Stage 1, haemorrhage and hard exudates; Stage 2, soft
exudates; Stage 3, intraretinal microvascular abnormalities
and venous changes including beading, loop and duplication;
Stage 4, new vessels, vitreous haemorrhage, fibrous prolifer-
ation and retinal detachment. The retinopathy endpoint was
(1) development of retinopathy (from Stage 0 to any other
stage confirmed in two continuous years), and (2) progression
from Stage 1 to Stage 3 or 4. The nephropathy endpoint was
defined as development of overt nephropathy (spot urinary
albumin excretion >300 mg/g creatinine in two consecutive
samples).
Macroangiopathy endpoints included the occurrence of
definite CHD (angina pectoris or myocardial infarction) or
stroke. Diagnosis of angina pectoris and myocardial
infarction was according to criteria defined by the WHO/
MONICA (Multinational Monitoring of Trends and Deter-
minants in Cardiovascular Disease) project and diagnosis of
stroke was according to guidelines defined by the Ministry
of Health, Labour and Welfare of Japan [21]. Information
regarding primary outcome and other clinical variables for
each patient was collected through an annual report from
each physician. Adjudication of endpoints was made by
central committees comprising experts in each complication
based on additional data such as CT or MRI of the brain or
sequential changes in electrocardiograms.
Statistical analysis The sample size required to compare
the net change in HbA1c level (level at the third year point
minus the baseline level) between the INT and CON groups
is based on a consideration of power. It is assumed that the
type I error (α) is 0.05 and the type II error (β) is 0.1;
therefore, in order to detect a difference of 0.2 in net change
in HbA1c level, with an SD of 1.0 among patients, a total
sample size of 1,025 is required. In addition, if allowance is
made for an up to 20% dropout rate, for 20% of the INT
group being unable to complete the intervention and for
10% of the CON group to change treatment method within
the follow-up period, the required sample size increases to
2,616. Thus, in terms of the feasibility of the study, it was
necessary to recruit more than 2,000 patients. All statistical
analyses and data management were conducted at a central
data centre. The Wilcoxon’s rank sum test, Fisher’s exact
test and Mantel’s test were used for comparison of
numerical and categorical variables between groups.
The study endpoints were analysed as time-to-event
variables, i.e. clinical data on patients who were lost during
follow-up were used for the period for which they could be
followed. Survival curves for the diabetic complications
were estimated by the Kaplan–Meier method, and the
logrank test was also conducted. Cox regression analysis
was used to calculate the unadjusted and adjusted HRs and
95% CIs for group and risk factors. In multivariate Cox
analysis, all significant variables selected for the univariate
422 Diabetologia (2010) 53:419–428analysis were used with the criterion of p<0.1. All values
are presented as means ± SD unless otherwise stated. All
p values are two-sided and the significance level is 0.05.
All statistical analyses were conducted using SAS packages
ver. 9.1 (SAS Institute, Cary, NC, USA).
Results
Clinical variables and their changes Clinical character-
istics of the patients at baseline and at the fourth and eighth
year after the start of the study are shown in Table 1. There
were no differences in most variables between the two
groups except for the triacylglycerol level, which was
slightly but significantly lower in the INT group at the
eighth year. Proportions of patients using agents for
hyperglycaemia, including insulin, hypertension and dysli-
pidaemia and anti-platelet agents did not differ significantly
between groups. Frequency of clinic visits also did not
differ between groups. Proportions of patients who satisfied
all or each of the components of the therapeutic goals did
not differ between groups at either the fourth or eighth year.
Median follow-up time was 7.8 years.
Of the eligible patients, 73% were followed into the
eighth year. The dropout rate, which was defined as the
proportion of patients who were lost-to-follow up until
the eighth year, in the INT group (24%) was significantly
lower than in the CON group (31%). Significant differences
in baseline characteristics between patients who completed
(i.e. were followed until the end of the observation period)
and did not complete (i.e. dropped out during the
observation period) follow-up were only found in the
proportion of patients on insulin (22% completed vs 18%
did not complete, p=0.03), in current smokers (20%
completed vs 7.5% did not complete, p=0.01) and amount
of daily exercise (590 kJ/day completed vs 351 kJ/day did
not complete, p<0.0001).
Effects of lifestyle modification There were no differences
in energy or fat intake between groups in either the fifth or
the eighth year of the study (Table 1). Physical activity as
determined by the Baecke’s Total Physical Activity Index
[27] after 5 years of intervention was significantly higher in
the INT group than in the CON group, with the difference
in the total score being derived from the Sports Index (4.1
in the INT group vs 3.7 in the CON group, p=0.028), but
not Work or Leisure Indices. The proportion of current
smokers in both groups decreased from 28% to 23%, with
no significance between groups.
Primary endpoint analysis During the study period, 345
retinopathy, 74 nephropathy, 115 CHD and 90 stroke events
occurred. Among all CHD events, 60% (n=69) were angina
pectoris and 40% (n=46) were myocardial infarction, and
among all stroke events, 83% (n=75) were brain infarction,
9% (n=8) were brain haemorrhage and 8% (n=7) were
transient ischaemic attack. Kaplan–Meier curves for macro-
and microvascular endpoints are shown in Fig. 2, which
demonstrates that the incidence of stroke in the INT group
was significantly lower than that in the CON group.
Risk factors for stroke analysed by univariate and
multivariate Cox proportional hazard models are shown in
Table 2, and belonging to the INT group was associated with
an approximately 40% significant risk reduction for stroke
by both univariate and multivariate analyses when all
significant variables determined by univariate analysis were
included. Systolic BP and lipoprotein(a) were also signifi-
cant factors that remained in multivariate analysis. Despite
this, absolute values for BP and lipoprotein(a) did not differ
significantly between groups. Even when myocardial infarc-
tion (including asymptomatic) or brain infarction was used
as an endpoint instead of CHD or stroke, respectively, the
above results were not changed (data not shown).
No group differences were found in the occurrence of
CHD, development of retinopathy (35.7/1,000 patient-years
in the CON group vs 39.0 in the INT group), progression of
retinopathy (6.5/1,000 patient-years in the CON group vs
10.0 in the INT group) or development of nephropathy
(6.7/1,000 patient-years in the CON group vs 6.7 in the INT
group).
Discussion
Although lifestyle interventions in patients with type 2
diabetes have traditionally focused almost exclusively on
weight loss, control of glycaemia and other major cardio-
vascular risk factors should also be considered simulta-
neously for the prevention of complications [28, 29].
Systematic reviews and meta-analyses have revealed
clinically significant but considerably mild effects of
lifestyle interventions on glycaemic control, that is about
a 0.5% reduction in HbA1c with some variations in HbA1c
levels depending on the study and its design [8, 11, 22, 23].
In the Steno-2 study [16], the difference in mean HbA1c
levels between the conventional and intensive therapy
groups after 7.8 years of follow-up was 1.1%, with a
marked reduction in many diabetic complications. This was
accomplished through not only behavioural modification
but also pharmacological therapy for control of glycaemia,
BP and serum lipid levels. HbA1c levels were not reported
in previous studies that examined the effects of a lifestyle
intervention on cardiovascular events in individuals with
IGT [13, 14]. The current study, together with our previous
interim report [21], added the information that a lifestyle
intervention produced significant but small and temporal
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424 Diabetologia (2010) 53:419–428improvement in glycaemic control and only minimal changes
in other known risk factors for diabetic complications,
indicating the difficulty in changing the lifestyle of patients
with long-term diabetes.
One possible reason for these limited effects on lifestyle
and risk factors was that the intensity of our lifestyle
intervention, which consisted only of education, was
considerably lower than that in other studies [3, 15]. The
rationale for this strategy was to determine if an interven-
tion that is practicable to apply in the clinical ‘real-world’
setting with limited resources would be effective. Our
results showed only very limited changes in actual lifestyle
as well as major risk factors.
Another reason for the limited effects is that, in our
study, even patients in the CON group received routine
lifestyle education by diabetes specialists, which is an
inevitable part of the usual care of persons with diabetes.
Consequently, the effects of the lifestyle intervention was
somewhat ‘diluted’. The sequential increase in mean weight
seen in the UK Prospective Diabetes Study (UKPDS) [30]
was not observed in this study even in the CON group,
indicating some effect of even routine lifestyle education.
Also, perhaps if individualised goals with designated per
cent changes for each patient in the INT group had been
established instead of uniform goals for the entire group,
results for the INT group might have been different. Further
examination of results might have indicated which sub-
groups within the INT group would be most likely to
benefit from such an intervention, which would be helpful
in planning future interventions.
Nevertheless, we found a significant reduced risk for
stroke in patients in the INT group compared with those in
the CON group regardless of the lack of significant
differences in most known cardiovascular risk factors. The
mechanism of this apparent contradictory result is yet to be
determined but it should be interpreted with care, especially
since BP, which is a major risk factor for stroke, did not
differ significantly between groups throughout the study
period. Multifactorial or combined effects of lifestyle
education/behaviours beyond individual factors [31] might
have existed but can only be speculated upon. At the same
time, the slight but significant differences in HbA1c in the
first 3 years, which was reported previously [21], but that
disappeared thereafter, could enhance the effects since past
interventions to lower HbA1c reportedly have had a very
long-term effect (i.e. ‘metabolic memory’ or ‘legacy effect’)
[32, 33].
Other speculations for the apparent contradictory result
include possible improvement in factors that were not
determined in this study, such as postprandial glycaemia/
lipaemia, BP at home or psychological factors (stress,
Fig. 2 Kaplan–Meier curves for each complication. a Nephropathy,
p=1.00. b Retinopathy, p=0.43. c CHD, p=0.40. d Stroke, p=0.02.
p values by logrank test. Dotted curves, CON; solid curves, INT
Table 2 Risk factors for stroke analysed by Cox univariate and
multivariate models
Variable HR (95% CI) p value
Univariate analysis
Sex (women vs men) 0.65 (0.42–1.00) 0.05
Age (per 10 years) 1.53 (1.11–2.13) 0.01
Diabetes duration (per 10 years) 0.95 (0.70–1.28) 0.72
HbA1c (per 1%) 1.12 (0.97–1.30) 0.13
BMI (per 1 kg/m
2) 1.05 (0.98–1.12) 0.18
Waist circumference (per 10 cm) 1.38 (1.09–1.74) 0.01
Systolic BP (per 10 mmHg) 1.22 (1.07–1.38) <0.01
Diastolic BP (per 10 mmHg) 1.18 (0.96–1.45) 0.12
LDL-cholesterol (per 1 mmol/l) 1.06 (0.82–1.37) 0.66
HDL-cholesterol (per 1 mmol/l) 0.62 (0.37–1.06) 0.08
Triacylglycerol (per 1 mmol/l) 1.16 (0.96–1.41) 0.14
Lipoprotein(a) (per 1 μmol/l) 1.17 (1.04–1.31) 0.01
Current smoker (yes vs no) 1.22 (0.95–1.56) 0.13
Alcohol intake (per 10 g ethanol) 1.06 (0.97–1.16) 0.23
Exercise amount (per 418 kJ) 1.01 (0.93–1.09) 0.80
INT group (vs CON group) 0.61 (0.39–0.93) 0.02
Multivariate analysis
Sex (women vs men) 0.68 (0.42–1.11) 0.12
Age (per 10 years) 1.42 (0.99–2.04) 0.06
Systolic BP (per 10 mmHg) 1.22 (1.05–1.40) 0.01
Lipoprotein(a) (per 1 μmol/l) 1.16 (1.03–1.31) 0.01
INT group (vs CON group) 0.62 (0.39–0.98) 0.04
All significant variables selected for the univariate analysis with the
criterion of a p<0.1 were used in the multivariate analysis
Diabetologia (2010) 53:419–428 425motivation or quality of life) [34] ,w h i c hc o u l db e
ameliorated in the INT group rather than in the CON
group. For example, Roumen et al. [35] recently reported
that a lifestyle intervention successfully improved post-
prandial glucose levels in IGT patients. Changes in diet
might also be effective, such as an increase in fruit intake,
which is reportedly associated with reduced CVD mortality
[36]. The reasons that only stroke, but not CHD or other
complications, was found to be responsive to our
intervention are speculated to include the following:
(1) stroke is more frequent than CHD in Japan compared
with other parts of the world, and (2) the independent risk
factor for stroke was only systolic BP and lipoprotein(a),
and so there would be room for other undetermined risk
factors to work.
Telephone counselling in patients with chronic disease
w a ss h o w nt ob ea s s o c i a t e dw i t ha4 1 %s i g n i f i c a n t
reduction in the risk of death [37]. However, attempts to
use telephone calls in diabetes care have resulted in
relatively mild [38, 39] or no additional [40] effects on
control variables or improved quality of life [41] or patient
satisfaction [39]. However, its effects on complication
events have not been determined previously. Current results
suggested that the telephone intervention could have
contributed to a reduction in complication events. Further
investigation is required to clarify whether telephone
counselling alone is effective in improving the occurrence
of complication events or death.
Lipoprotein(a), primarily a genetically determined risk
factor for atherothrombogenesis, was found to be one
significant predictor of stroke in our analysis. It has been
reported as a predictor of deterioration of renal function
[42], peripheral arterial disease [43], CVD [44] including
CHD [45], and cardiovascular mortality [46] in patients
with type 2 diabetes and a predictor of CVD [47] in patients
with type 1 diabetes. It is of interest that the serum level of
lipoprotein(a), which is known to be less affected by
lifestyle or medication than other cardiovascular risk factors
[48], was also a significant factor independent from
lifestyle in our cohort.
The strengths of our study are that (1) it is the first
intervention study mainly focused on the effects of lifestyle
education on diabetic vascular complications, and (2) follow-
up was done by diabetes specialists, ensuring that the quality
of data was relatively high. Nevertheless, we acknowledge
that the study had certain limitations. First, our partic-
ipants were hospital-based patients with diabetes of a
relatively long duration. Therefore, we cannot make
inferences beyond a similar group. Second, only Asian
diabetic patients were involved and they are different from
other ethnic groups in terms of degree of obesity [49].
Third, we had a low follow-up rate, since the study was
done mainly in large hospitals in urban areas where
patients move quite frequently. However, it is less likely
that this could be a cause of an inter-group difference in
stroke incidence since significant differences in the
incidence of stroke between groups could already be
seen 4–5 years after the intervention began, when the
follow-up rates of the two groups were not significantly
different.
A therapeutic intervention mainly focused on lifestyle
changes produced a significantly reduced risk of stroke in
Japanese patients with type 2 diabetes independently of
known classic risk factors. The detailed mechanisms for
this effect should be investigated in the future.
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